Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.
about
Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Portal hypertension is associa ...... with hepatocellular carcinoma.
@en
Portal hypertension is associa ...... with hepatocellular carcinoma.
@nl
type
label
Portal hypertension is associa ...... with hepatocellular carcinoma.
@en
Portal hypertension is associa ...... with hepatocellular carcinoma.
@nl
prefLabel
Portal hypertension is associa ...... with hepatocellular carcinoma.
@en
Portal hypertension is associa ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
Portal hypertension is associa ...... with hepatocellular carcinoma.
@en
P2093
Dong Ho Lee
Hwan Jun Jae
Jin Woo Choi
Myungsu Lee
Saebeom Hur
P2860
P2888
P304
P356
10.1007/S00330-017-5145-9
P407
P577
2017-12-07T00:00:00Z